ClinicalTrials.gg
Not yet recruitingNCT07570784Updated Jun 5, 2026

Stability of Hand Grip Strength Across a Competitive Season in Elite Male and Female Ice Hockey Players

An observational study in Ice Hockey, Grip Strength and Within-season Variability, sponsored by Dalarna County Council, Sweden. Not yet recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-05.

Sponsored by Dalarna County Council, Sweden · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Study summary

This study examines how hand grip strength changes over the course of a competitive ice hockey season in elite male and female players.

Hand grip strength is a simple and widely used measure of upper-body strength and functional capacity. It is often used in sports science and clinical settings, but it is unclear whether grip strength remains stable throughout a season or changes depending on training load, match exposure, and fatigue.

In this study, elite ice hockey players from Swedish teams will have their grip strength measured at four timepoints during one season: pre-season, early season, mid-season, and late season. Both dominant and non-dominant hand strength will be assessed using a standardized dynamometer and protocol.

The main purpose is to determine how much grip strength varies within individual players over time and whether a single measurement can be considered representative of a player's true strength level across a season. The study will also evaluate the reliability of grip strength measurements and whether observed changes are large enough to be meaningful in a clinical or performance context.

No intervention is performed, and all measurements are non-invasive and conducted as part of routine testing environments within participating teams.

Read the detailed description

This is a prospective longitudinal observational cohort study designed to evaluate within-season variability and measurement stability of maximal isometric hand grip strength in elite ice hockey players.

Hand grip strength is widely used as a surrogate marker of upper-limb strength and general neuromuscular capacity. Although its reliability has been well described in clinical and general athletic populations when measured using standardized protocols, limited evidence exists regarding its temporal stability in elite collision sport athletes over an entire competitive season. In particular, it remains unclear whether grip strength behaves as a stable individual characteristic or whether it is influenced by seasonal training load, match congestion, fatigue, or adaptation effects.

The study will include elite male and female ice hockey players recruited from Swedish top-level teams. Participants will undergo repeated standardized grip strength assessments at four predefined timepoints across one competitive season: pre-season baseline, early mid-season, late mid-season, and pre-playoff/end-of-season phase. All measurements will be performed using a calibrated hand dynamometer following a standardized protocol based on established clinical measurement guidelines, including consistent body positioning, handle adjustment, and repeated maximal trials for both dominant and non-dominant hands. Mean values from repeated trials will be used for analysis.

To reduce measurement variability, all testing will be conducted by trained assessors using harmonized instructions across participating teams. Where possible, testing sessions will be scheduled to minimize acute fatigue effects by ensuring a standardized recovery period following matches or high-intensity training sessions.

The primary analytical focus is within-subject variability of grip strength across the season, quantified using measures of dispersion and reliability, including coefficient of variation (CV%), within-subject standard deviation, and intraclass correlation coefficients (ICC). Additional analyses will estimate measurement error (standard error of measurement) and minimal detectable change (MDC95) to determine the smallest meaningful change in grip strength that exceeds expected measurement noise.

Longitudinal changes in grip strength across the season will be assessed using mixed-effects statistical models to account for repeated measures within individuals and potential group-level effects such as sex and playing level.

The study does not involve any interventions, treatment allocation, or experimental manipulation. All assessments are non-invasive and conducted within routine team environments. The findings are intended to inform interpretation of grip strength in athletic monitoring, rehabilitation contexts, and performance evaluation, specifically whether single timepoint measurements can be reliably used for comparison against normative data or whether seasonality must be considered in clinical and performance decision-making.

02

Conditions studied

  • Ice Hockey
  • Grip Strength
  • Within-season Variability

Keywords

  • ice hockey
  • hand grip strength
  • within-season variability
  • test-retest reliability
03

In context

Lead sponsor

Dalarna County Council, Sweden is the lead sponsor of 28 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

150

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Contracted elite ice hockey players in participating Swedish teams (SHL, HockeyAllsvenskan, SDHL or equivalent top division)
  • Male or female players competing at elite level
  • Available for testing at all predefined measurement timepoints across the season
  • Able to perform maximal hand grip strength testing
  • Provides

Exclusion criteria

Exclusion Criteria:

  • Acute hand or wrist injury at baseline preventing maximal grip strength testing
  • Any condition during the study period preventing completion of repeated grip strength assessments
  • Inability to participate in all scheduled measurement sessions
  • Refusal to participate
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Elite Ice Hockey Players Cohort

    Elite male and female ice hockey players from Swedish top-level teams (SHL, HockeyAllsvenskan, SDHL). Participants undergo repeated standardized measurements of hand grip strength across four predefined timepoints during one competitive season (pre-season, early season, mid-season, and pre-playoff/end-of-season). The same individuals are followed longitudinally to assess within-subject variability and stability of grip strength over time.

06

What researchers measure

Primary outcomes

  1. Within-Subject Variability of Hand Grip Strength

    Within-subject variability of maximal isometric hand grip strength across a competitive season in elite ice hockey players, expressed as coefficient of variation (CV%) across repeated measurements.

    Time frame: From baseline (pre-season) to end of season (pre-playoff), up to 8 months

Secondary outcomes

  1. Test-Retest Reliability of Hand Grip Strength

    Reliability of repeated grip strength measurements across the season assessed using intraclass correlation coefficient (ICC).

    Time frame: From baseline (pre-season) to end of season (pre-playoff), up to 8 months

  2. Within-Subject Standard Deviation of Grip Strength

    Absolute within-player variability in grip strength across the competitive season.

    Time frame: From baseline (pre-season) to end of season (pre-playoff), up to 8 months

  3. Standard Error of Measurement (SEM)

    Measurement error of grip strength across repeated seasonal assessments.

    Time frame: From baseline (pre-season) to end of season (pre-playoff), up to 8 months

  4. Minimal Detectable Change (MDC95)

    Smallest change in grip strength considered beyond measurement error with 95% confidence.

    Time frame: From baseline (pre-season) to end of season (pre-playoff), up to 8 months

  5. Seasonal Change in Grip Strength

    Systematic changes in maximal grip strength across the competitive season assessed using longitudinal mixed-effects models.

    Time frame: From baseline (pre-season) to end of season (pre-playoff), up to 8 months

07

Study locations

1 site
08

References and documents

Publications

  • Toong T, Wilson KE, Urban K, Paniccia M, Hunt AW, Keightley M, Reed N. Grip Strength in Youth Ice Hockey Players: Normative Values and Predictors of Performance. J Strength Cond Res. 2018 Dec;32(12):3494-3502. doi: 10.1519/JSC.0000000000002815. PubMed 30216250 ↗
  • Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, Sayer AA. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011 Jul;40(4):423-9. doi: 10.1093/ageing/afr051. Epub 2011 May 30. PubMed 21624928 ↗

Individual participant data

Plan to share: Yes — Any data shared with colleagues or collaborating researchers will be fully anonymized or pseudonymized to protect participant privacy in accordance with GDPR regulations. Data transfers will occur under strict confidentiality agreements, and all parties will adhere to applicable data protection laws to ensure the security and privacy of personal information. We will act in accordance with the ethical approval granted by the Swedish Ethical Review Authority (EPM) and comply with all relevant local policies regarding data protection.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: From the publication of the protocol and for 10 years thereafter.

Access criteria: Access to individual participant data is typically restricted to authorized researchers involved in the study or approved collaborators under strict confidentiality and data protection agreements.

Data sharing details ↗ · swehip.se

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Apr 2027, 7 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2026
First posted
May 6, 2026
StartEst.
Sep 2026
Primary completionEst.
Apr 30, 2027
CompletionEst.
Dec 31, 2027
Last update
Jun 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07570784
Lead sponsor
Dalarna County Council, Sweden
Responsible party
Daniel Muder (Principal Investigator., Dalarna County Council, Sweden) — Principal investigator
First posted
May 6, 2026
Start date
Sep 2026 (estimated)
Primary completion
Apr 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Jun 5, 2026

Study contacts

Daniel Muder, MD, PhD
Contact
danielmuder@email.com
+46722027596
Tomas Hultgren, MD
Contact
tomas.hultgren@hotmail.com

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion